Pre-Seed Opportunity | $2.5M Capital Raise

Ending the
$341B Global Crisis

Breastfeeding is the only vital sign managed by intuition alone. We're fixing that with The Milk Graph™.

Woman with MonBe Device
$15.42B
Total TAM
The Milk Graph™
$85M-$640M Data Value
$1.5B
Year 10 Revenue
15-80x
Investor ROI

The Global Crisis & Clinical Standards

WHO/UNICEF set ambitious breastfeeding targets. Current reality falls catastrophically short—creating a $341B global crisis.

WHO/UNICEF 2030 Targets

60-70%

Exclusive Breastfeeding (0–6 months)

70%

Early Initiation (within 1 hour)

80%

Continued at 1 year

Current Reality (2024-2025)

8.77M births in Western markets annually

83%

Initiate breastfeeding in Western countries

40%

Quit within 3 months due to supply anxiety without data

700K

Preventable Child Deaths Annually

1,500 deaths every day

$341B

Annual Global Economic Loss

$285B in cognitive losses

$644K

Lost per Medium Hospital/Year

Preventable readmissions

Introducing The Milk Graph™

The world's first proprietary dataset on real-time infant intake and latch efficiency. Our primary clinical moat.

Data Monetization Potential: $85M–$640M/year

Session Data

Volume & Flow

Volume (ml), Flow Rate (ml/min), letdown timing, breast emptying efficiency

Infant Data

Latch Efficiency

Sucking vigor, rhythm, active vs. passive feeding time

Maternal Data

Supply Predictors

Impact of diet, sleep, and stress on supply

Data Monetization Pathways

$40-80M
Insurers

Prevent $9,500 readmissions via predictive analytics

$50-100M
Formula Companies

Understand "mixed feeding" triggers for 60% of mothers

$30-60M
Pharma

Objective endpoints for galactagogue drug trials

The MonBe Solution

Multi-sensor, AI-powered lactation monitoring system with 30-40% higher accuracy than single-sensor competitors

Multi-Sensor Fusion: The Technical Edge

6
Sensor Modalities
30-40%
Higher Accuracy vs Competitors
1st
In Market Position

Ultrasound, Pressure, NIR, Bioimpedance, Accelerometers, Microphones work together for unprecedented accuracy

Hardware UX: Simple Yet Sophisticated

1

Apply

Reusable core + disposable breast patch. NFC-based, no Bluetooth near baby

2

Feed

6 sensors capture volume, flow, latch quality. Real physiological data

3

Sync

NFC transfer to phone. 3-week battery life, zero radiation during feeding

Technical Specifications

MD-001 Clinical Specifications

Ultrasound (MHz Piezo)
Flow Segmentation
Bioimpedance (4-Electrode)
Liquid Displacement
Acoustic Monitoring
Swallow Density
Pneumatic Sensing (MP3V5010DP)
Vacuum & Latch
IMU Engine (Bosch BMI270)
6-Axis Motion
Thermal Precise (TMP117)
±0.1°C Monitoring

Ultrasound (MHz Piezo)

Tracks swallow volume dynamics in real-time. This provides the ground-truth intake data for The Milk Graph™.

MonBe vs Competitors Spider Graph

$15.42B Total Addressable Market

Multiple revenue streams across consumer, hospital, government, and international markets

Revenue Stream Breakdown

Revenue Stream Value % of TAM
Consumer (B2C) $4.75B 31.7%
Hospitals (B2B) $4.50B 30.0%
International Expansion $1.91B 12.7%
Government/WIC $1.66B 11.1%
Pharmacy/Retail $800M 5.3%
Professional/IBCLC $500M 3.3%
Pediatrics & Data Analytics $300M 2.0%
TOTAL TAM $15.42B 100%
Pathway 1

RPM (Primary)

CPT codes provide $565.15 reimbursement over 6 months

$565
Per Patient / 6 Months
Pathway 2

ACA Mandate

Section 2713 requires 100% coverage with zero cost-sharing

100%
Coverage Required
Pathway 3

Hospital Enterprise

ROI-based pricing capturing $2.8M potential savings

$25K-150K
Annual / Hospital

Financial Projections

$0.7M-$2.2M
Year 1 Revenue
$1.5B
Year 10 Revenue (10% penetration)
$8B-$15B
Exit Valuation (10-12x multiple)

The Investment Ask

$2,500,000
Pre-Seed Capital

SAFE or Convertible Note | Projected 15-80x Investor ROI

Use of Funds

MVP

Complete hardware + software development

FDA

510(k) & CE Mark submission

Validation

Clinical validation & hospital pilots

Team

Key executive hires

Execution Roadmap

Year 1

Consumer Launch

5K-10K paying mothers, MVP, initial clinical data

Year 2-3

FDA & Hospital Pilots

510(k) clearance, 3-5 hospital pilots, Series A

Year 4-5

Scale & Expansion

50-100 hospitals, Nordic expansion, $150M-$200M ARR

Year 10

Exit

$1.5B revenue, strategic acquisition or IPO

Key Metrics

Consumer LTV $560+
Hospital LTV $500K+
LTV:CAC Ratio 8:1
Gross Margins 70%+
Exit Valuation $8B-$15B

The Team

Eitan Halfon – CEO & Founder

Electrical Engineer (BSc) | Ex-SolarEdge (NASDAQ: SEDG) | MSc Global Financial Economics | Former Military Officer

Contact Information

Website: monbecare.com
Investment Inquiries: investors@monbe.com